| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.03 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |